Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 137

1.

Peripheral blood immune cell methylation profiles are associated with nonhematopoietic cancers.

Koestler DC, Marsit CJ, Christensen BC, Accomando W, Langevin SM, Houseman EA, Nelson HH, Karagas MR, Wiencke JK, Kelsey KT.

Cancer Epidemiol Biomarkers Prev. 2012 Aug;21(8):1293-302. doi: 10.1158/1055-9965.EPI-12-0361. Epub 2012 Jun 19.

2.

Leukocyte-adjusted epigenome-wide association studies of blood from solid tumor patients.

Langevin SM, Houseman EA, Accomando WP, Koestler DC, Christensen BC, Nelson HH, Karagas MR, Marsit CJ, Wiencke JK, Kelsey KT.

Epigenetics. 2014 Jun;9(6):884-95. doi: 10.4161/epi.28575. Epub 2014 Mar 26.

3.

Peripheral blood DNA methylation profiles are indicative of head and neck squamous cell carcinoma: an epigenome-wide association study.

Langevin SM, Koestler DC, Christensen BC, Butler RA, Wiencke JK, Nelson HH, Houseman EA, Marsit CJ, Kelsey KT.

Epigenetics. 2012 Mar;7(3):291-9. doi: 10.4161/epi.7.3.19134.

4.

Similar blood-borne DNA methylation alterations in cancer and inflammatory diseases determined by subpopulation shifts in peripheral leukocytes.

Li H, Zheng T, Chen B, Hong G, Zhang W, Shi T, Li S, Ao L, Wang C, Guo Z.

Br J Cancer. 2014 Jul 29;111(3):525-31. doi: 10.1038/bjc.2014.347. Epub 2014 Jun 24.

5.

DNA methylation array analysis identifies profiles of blood-derived DNA methylation associated with bladder cancer.

Marsit CJ, Koestler DC, Christensen BC, Karagas MR, Houseman EA, Kelsey KT.

J Clin Oncol. 2011 Mar 20;29(9):1133-9. doi: 10.1200/JCO.2010.31.3577. Epub 2011 Feb 22.

6.

Epigenetic profiling reveals etiologically distinct patterns of DNA methylation in head and neck squamous cell carcinoma.

Marsit CJ, Christensen BC, Houseman EA, Karagas MR, Wrensch MR, Yeh RF, Nelson HH, Wiemels JL, Zheng S, Posner MR, McClean MD, Wiencke JK, Kelsey KT.

Carcinogenesis. 2009 Mar;30(3):416-22. doi: 10.1093/carcin/bgp006. Epub 2009 Jan 6.

7.

Identification of FOXM1-induced epigenetic markers for head and neck squamous cell carcinomas.

Hwang S, Mahadevan S, Qadir F, Hutchison IL, Costea DE, Neppelberg E, Liavaag PG, Waseem A, Teh MT.

Cancer. 2013 Dec 15;119(24):4249-58. doi: 10.1002/cncr.28354. Epub 2013 Oct 1.

8.

DNA methylation arrays as surrogate measures of cell mixture distribution.

Houseman EA, Accomando WP, Koestler DC, Christensen BC, Marsit CJ, Nelson HH, Wiencke JK, Kelsey KT.

BMC Bioinformatics. 2012 May 8;13:86. doi: 10.1186/1471-2105-13-86.

9.

Global DNA methylation level in whole blood as a biomarker in head and neck squamous cell carcinoma.

Hsiung DT, Marsit CJ, Houseman EA, Eddy K, Furniss CS, McClean MD, Kelsey KT.

Cancer Epidemiol Biomarkers Prev. 2007 Jan;16(1):108-14.

10.

FOXM1 induces a global methylation signature that mimics the cancer epigenome in head and neck squamous cell carcinoma.

Teh MT, Gemenetzidis E, Patel D, Tariq R, Nadir A, Bahta AW, Waseem A, Hutchison IL.

PLoS One. 2012;7(3):e34329. doi: 10.1371/journal.pone.0034329. Epub 2012 Mar 26.

11.

Protein expression and promoter methylation of the candidate biomarker TCF21 in head and neck squamous cell carcinoma.

Weiss D, Stockmann C, Schrödter K, Rudack C.

Cell Oncol (Dordr). 2013 Jun;36(3):213-24. doi: 10.1007/s13402-013-0129-5. Epub 2013 Mar 26.

PMID:
23529585
12.
13.

Genetic and epigenetic somatic alterations in head and neck squamous cell carcinomas are globally coordinated but not locally targeted.

Poage GM, Christensen BC, Houseman EA, McClean MD, Wiencke JK, Posner MR, Clark JR, Nelson HH, Marsit CJ, Kelsey KT.

PLoS One. 2010 Mar 11;5(3):e9651. doi: 10.1371/journal.pone.0009651.

14.

Examination of a CpG island methylator phenotype and implications of methylation profiles in solid tumors.

Marsit CJ, Houseman EA, Christensen BC, Eddy K, Bueno R, Sugarbaker DJ, Nelson HH, Karagas MR, Kelsey KT.

Cancer Res. 2006 Nov 1;66(21):10621-9.

15.

Genome-wide analysis of CpG island methylation in bladder cancer identified TBX2, TBX3, GATA2, and ZIC4 as pTa-specific prognostic markers.

Kandimalla R, van Tilborg AA, Kompier LC, Stumpel DJ, Stam RW, Bangma CH, Zwarthoff EC.

Eur Urol. 2012 Jun;61(6):1245-56. doi: 10.1016/j.eururo.2012.01.011. Epub 2012 Jan 18.

PMID:
22284968
16.

Decreased NK cells in patients with head and neck cancer determined in archival DNA.

Accomando WP, Wiencke JK, Houseman EA, Butler RA, Zheng S, Nelson HH, Kelsey KT.

Clin Cancer Res. 2012 Nov 15;18(22):6147-54. doi: 10.1158/1078-0432.CCR-12-1008. Epub 2012 Sep 26.

17.

Epigenome-wide scans identify differentially methylated regions for age and age-related phenotypes in a healthy ageing population.

Bell JT, Tsai PC, Yang TP, Pidsley R, Nisbet J, Glass D, Mangino M, Zhai G, Zhang F, Valdes A, Shin SY, Dempster EL, Murray RM, Grundberg E, Hedman AK, Nica A, Small KS; MuTHER Consortium, Dermitzakis ET, McCarthy MI, Mill J, Spector TD, Deloukas P.

PLoS Genet. 2012;8(4):e1002629. doi: 10.1371/journal.pgen.1002629. Epub 2012 Apr 19.

18.
19.

LINE-1 and Alu methylation patterns in lymph node metastases of head and neck cancers.

Kitkumthorn N, Keelawat S, Rattanatanyong P, Mutirangura A.

Asian Pac J Cancer Prev. 2012;13(9):4469-75.

20.

An epigenetic signature in peripheral blood predicts active ovarian cancer.

Teschendorff AE, Menon U, Gentry-Maharaj A, Ramus SJ, Gayther SA, Apostolidou S, Jones A, Lechner M, Beck S, Jacobs IJ, Widschwendter M.

PLoS One. 2009 Dec 18;4(12):e8274. doi: 10.1371/journal.pone.0008274.

Items per page

Supplemental Content

Write to the Help Desk